 |
October 8, 2008 – Cato T. Laurencin, M.D., Ph.D. Scientific Founder and Robert S. Langer, Sc.D Director of Soft Tissue Regeneration, Inc. named to the American Institute of Chemical Engineers list of the top 100 chemical engineers of the modern era. Link: [PDF Document] |
|
On September 2, 2008, Soft Tissue Regeneration, Inc. announced that it has closed on a $3.5 million Series A financing led by MentorTech Ventures (Philadelphia, PA). Link: [PDF Document] |
|
July 23, 2008 - ESPN - 7 things You Should Know About by Dr. James Andrews, Soft Tissue Regeneration Board Member.
Link: [HTML] (opens in a new window) |
|
June 12, 2008 - MOVERS: Cato Laurencin, vice-president for healthaffairs, University of Connecticut Health Center, and dean, University of Connecticut School of Medicine, Farmington. Link: [PDF Document] |
|
June 11, 2008 – Helsinki Finland - The 2008 Millennium Technology Prize was presented to Soft Tissue Regeneration, LLC Board of Directors Member and Scientific Advisory Board Member, Professor Robert Langer today in Helsinki for developing innovative biomaterials for controlled drug release. Link: [HTML] (opens in a new window) |
|
May 19, 2008 - Cato T. Laurencin, M.D., Ph.D., Founder and Chief Science Officer of Soft Tissue Regeneration, LLC, has been named Dean of the University of Connecticut School of Medicine and Vice President of the University of Connecticut Health Center. Link: [HTML] (opens in a new window) |
|
April 22, 2008 – Herndon, Va. – The Center for Innovative Technology (CIT) today announced that CIT GAP Funds is leading an investment round in Soft Tissue Regeneration, LLC (STR), a medical device company based in Earlysville, VA, that develops synthetic scaffolds to encourage tissue regeneration. Links: [HTML] [Word Document] |
|
January 2, 2008 – Cato T. Laurencin, M.D., Ph.D., University Professor, Professor and Chair of Orthopaedic Surgery and Professor of Biomedical Engineering and Chemical Engineering at the University of Virginia, has been named to the 2007 Scientific American 50 ”SciAm 50” for his groundbreaking technology for regeneration of the anterior cruciate ligament (ACL) using a bioengineered matrix. Links: [HTML] [Word Document]
|
